• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.数据分析的透明度和可重复性:前列腺癌预防试验。
Biostatistics. 2010 Jul;11(3):413-8. doi: 10.1093/biostatistics/kxq004. Epub 2010 Feb 19.
2
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection.非那雄胺可提高直肠指检对前列腺癌检测的敏感度。
J Urol. 2007 May;177(5):1749-52. doi: 10.1016/j.juro.2007.01.071.
3
The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels.非那雄胺对血清前列腺特异性抗原水平升高的男性前列腺的影响。
Br J Cancer. 1998 Aug;78(3):413-8. doi: 10.1038/bjc.1998.508.
4
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer.非那雄胺对前列腺特异性抗原(PSA)检测前列腺癌敏感性的影响。
J Natl Cancer Inst. 2006 Aug 16;98(16):1128-33. doi: 10.1093/jnci/djj307.
5
Prostate cancer prevention and finasteride.前列腺癌预防与非那雄胺
J Urol. 2006 Nov;176(5):2010-2; discussion 2012-3. doi: 10.1016/j.juro.2006.07.045.
6
Prostate cancer prevention with 5 alpha-reductase inhibitors.使用5α-还原酶抑制剂预防前列腺癌。
Recent Results Cancer Res. 2011;188:109-14. doi: 10.1007/978-3-642-10858-7_9.
7
Prostate cancer chemoprevention: update of the prostate cancer prevention trial findings and implications for clinical practice.前列腺癌化学预防:前列腺癌预防试验结果的更新及其对临床实践的意义。
Curr Oncol Rep. 2008 Nov;10(6):529-32. doi: 10.1007/s11912-008-0080-1.
8
Evaluation of men on finasteride.对服用非那雄胺的男性进行评估。
Semin Urol Oncol. 1996 Aug;14(3):139-44.
9
Finasteride decreases the risk of prostatic intraepithelial neoplasia.非那雄胺可降低前列腺上皮内瘤变的风险。
J Urol. 2007 Jul;178(1):107-9; discussion 110. doi: 10.1016/j.juro.2007.03.012. Epub 2007 May 11.
10
Implementation of the Prostate Cancer Prevention Trial (PCPT).前列腺癌预防试验(PCPT)的实施。
Control Clin Trials. 2004 Apr;25(2):203-22. doi: 10.1016/j.cct.2003.11.007.

引用本文的文献

1
A review of reproducible and transparent research practices in urology publications from 2014 to2018.2014 年至 2018 年泌尿科出版物中可重复和透明研究实践的回顾。
BMC Urol. 2022 Jul 11;22(1):102. doi: 10.1186/s12894-022-01059-8.
2
Maximum likelihood estimation with missing outcomes: From simplicity to complexity.最大似然估计在缺失结局中的应用:从简单到复杂。
Stat Med. 2019 Sep 30;38(22):4453-4474. doi: 10.1002/sim.8319. Epub 2019 Aug 8.
3
How to interpret a small increase in AUC with an additional risk prediction marker: decision analysis comes through.如何解释 AUC 随着额外风险预测标志物的增加而略有增加:决策分析派上用场。
Stat Med. 2014 Sep 28;33(22):3946-59. doi: 10.1002/sim.6195. Epub 2014 May 13.
4
Quantifying reproducibility in computational biology: the case of the tuberculosis drugome.量化计算生物学中的可重复性:以结核药物组为例。
PLoS One. 2013 Nov 27;8(11):e80278. doi: 10.1371/journal.pone.0080278. eCollection 2013.

本文引用的文献

1
Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis.非那雄胺是否会影响前列腺癌的严重程度?因果敏感性分析。
J Am Stat Assoc. 2008 Dec 1;103(484):1392-1404. doi: 10.1198/016214508000000706.
2
Reproducible research and Biostatistics.可重复性研究与生物统计学。
Biostatistics. 2009 Jul;10(3):405-8. doi: 10.1093/biostatistics/kxp014.
3
Estimating rates of true high-grade disease in the prostate cancer prevention trial.在前列腺癌预防试验中估计真正高级别疾病的发生率。
Cancer Prev Res (Phila). 2008 Aug;1(3):182-6. doi: 10.1158/1940-6207.CAPR-07-0007. Epub 2008 May 18.
4
Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.非那雄胺不会增加高级别前列腺癌的风险:一种偏差调整建模方法。
Cancer Prev Res (Phila). 2008 Aug;1(3):174-81. doi: 10.1158/1940-6207.CAPR-08-0092. Epub 2008 May 18.
5
Simple adjustments for randomized trials with nonrandomly missing or censored outcomes arising from informative covariates.针对因信息性协变量导致非随机缺失或删失结局的随机试验的简单调整。
Biostatistics. 2006 Jan;7(1):29-40. doi: 10.1093/biostatistics/kxi038. Epub 2005 May 27.
6
The influence of finasteride on the development of prostate cancer.非那雄胺对前列腺癌发生发展的影响。
N Engl J Med. 2003 Jul 17;349(3):215-24. doi: 10.1056/NEJMoa030660. Epub 2003 Jun 24.

数据分析的透明度和可重复性:前列腺癌预防试验。

Transparency and reproducibility in data analysis: the Prostate Cancer Prevention Trial.

机构信息

Biometry Research Group, Division of Cancer Prevention, National Cancer Institute, 6130 Executive Boulevard, Bethesda, MD 20892-7354, USA.

出版信息

Biostatistics. 2010 Jul;11(3):413-8. doi: 10.1093/biostatistics/kxq004. Epub 2010 Feb 19.

DOI:10.1093/biostatistics/kxq004
PMID:20173101
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2883301/
Abstract

With the analysis of complex, messy data sets, the statistics community has recently focused attention on "reproducible research," namely research that can be readily replicated by others. One standard that has been proposed is the availability of data sets and computer code. However, in some situations, raw data cannot be disseminated for reasons of confidentiality or because the data are so messy as to make dissemination impractical. For one such situation, we propose 2 steps for reproducible research: (i) presentation of a table of data and (ii) presentation of a formula to estimate key quantities from the table of data. We illustrate this strategy in the analysis of data from the Prostate Cancer Prevention Trial, which investigated the effect of the drug finasteride versus placebo on the period prevalence of prostate cancer. With such an important result at stake, a transparent analysis was important.

摘要

随着对复杂、混乱数据集的分析,统计学界最近将注意力集中在“可重现研究”上,即其他研究人员可以轻松复制的研究。已经提出的一个标准是数据集和计算机代码的可用性。然而,在某些情况下,出于保密原因或因为数据过于混乱而无法传播,原始数据无法传播。对于这种情况之一,我们提出了可重现研究的 2 个步骤:(i)呈现数据表格,(ii)呈现从数据表中估计关键数量的公式。我们在分析前列腺癌预防试验的数据时说明了这种策略,该试验研究了药物非那雄胺与安慰剂对前列腺癌期间流行率的影响。由于这个重要结果的存在,透明的分析是很重要的。